Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junfei Wei

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Parasitology Research|September 9, 2017
Identification, Characterization, and Structure of Tm16 from <i>Trichuris muris</i>Zhuyun Liu, Alan Kelleher, Shanii Tabb, et al.
Parasites & Vectors|September 29, 2016
The hookworm Ancylostoma ceylanicum intestinal transcriptome provides a platform for selecting drug and vaccine candidatesJunfei Wei, Ashish Damania, Xin Gao, et al.
Plos Neglected Tropical Diseases|April 6, 2016
Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi InfectionSridhar Arumugam, Junfei Wei, Zhuyun Liu, et al.
Plos Neglected Tropical Diseases|February 14, 2020
Protective immunity elicited by the nematode-conserved As37 recombinant protein against Ascaris suum infectionLeroy Versteeg, Junfei Wei, Zhuyun Liu, et al.
Tropical Medicine & International Health : TM & IH|October 2, 2015
Identification of immunodominant antigens for the laboratory diagnosis of toxocariasisBin Zhan, Ravi Ajmera, Stefan Michael Geiger, et al.
Applied Microbiology and Biotechnology|May 7, 2021
Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain-based vaccine candidate, RBD219-N1C1Jungsoon Lee, Zhuyun Liu, Wen-Hsiang Chen, et al.
Frontiers in Immunology|February 24, 2022
Mucosal Vaccination With Recombinant <i>Tm-</i>WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR MiceJunfei Wei, Venkatesh L Hegde, Ananta V Yanamandra, et al.
Vaccine|May 17, 2018
The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4<sup>+</sup> T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathwaySonia Jain, Parakkal Jovvian George, Wanyan Deng, et al.
Protein Expression and Purification|October 30, 2016
Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasisC Patrick McAtee, Christopher A Seid, Molly Hammond, et al.
Plos Neglected Tropical Diseases|July 15, 2017
Yeast-expressed recombinant As16 protects mice against Ascaris suum infection through induction of a Th2-skewed immune responseJunfei Wei, Leroy Versteeg, Zhuyun Liu, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Parasitology Research|September 9, 2017
Identification, Characterization, and Structure of Tm16 from <i>Trichuris muris</i>Zhuyun Liu, Alan Kelleher, Shanii Tabb, et al.
Parasites & Vectors|September 29, 2016
The hookworm Ancylostoma ceylanicum intestinal transcriptome provides a platform for selecting drug and vaccine candidatesJunfei Wei, Ashish Damania, Xin Gao, et al.
Plos Neglected Tropical Diseases|April 6, 2016
Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi InfectionSridhar Arumugam, Junfei Wei, Zhuyun Liu, et al.
Plos Neglected Tropical Diseases|February 14, 2020
Protective immunity elicited by the nematode-conserved As37 recombinant protein against Ascaris suum infectionLeroy Versteeg, Junfei Wei, Zhuyun Liu, et al.
Tropical Medicine & International Health : TM & IH|October 2, 2015
Identification of immunodominant antigens for the laboratory diagnosis of toxocariasisBin Zhan, Ravi Ajmera, Stefan Michael Geiger, et al.
Applied Microbiology and Biotechnology|May 7, 2021
Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain-based vaccine candidate, RBD219-N1C1Jungsoon Lee, Zhuyun Liu, Wen-Hsiang Chen, et al.
Frontiers in Immunology|February 24, 2022
Mucosal Vaccination With Recombinant <i>Tm-</i>WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR MiceJunfei Wei, Venkatesh L Hegde, Ananta V Yanamandra, et al.
Vaccine|May 17, 2018
The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4<sup>+</sup> T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathwaySonia Jain, Parakkal Jovvian George, Wanyan Deng, et al.
Protein Expression and Purification|October 30, 2016
Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasisC Patrick McAtee, Christopher A Seid, Molly Hammond, et al.
Plos Neglected Tropical Diseases|July 15, 2017
Yeast-expressed recombinant As16 protects mice against Ascaris suum infection through induction of a Th2-skewed immune responseJunfei Wei, Leroy Versteeg, Zhuyun Liu, et al.
Pageof 4